House Bill 5926
115th Congress(2017-2018)
Naloxone Guidelines Act of 2018
Introduced
Introduced in House on May 23, 2018
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5926
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Naloxone Guidelines Act of 2018
This bill requires the Department of Health and Human Services to issue guidelines for prescribing an opioid overdose reversal drug (e.g., naloxone).
The guidelines must address issues relating to the distribution, education, and safety of opioid overdose reversal drugs, including:
- co-prescription with an opioid;
- safe dosages;
- prescription for non-patients; and
- standing orders (i.e., orders that allow dispensing without a prescription).
May 23, 2018
Sort by most recent
05/23/2018
Referred to the House Committee on Energy and Commerce.
05/23/2018
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:39:27 PM